Market Data graphic

Sciences biologiques

Vous êtes ici

Le secteur des sciences biologiques comprend des sociétés dont les activités concernent les produits biopharmaceutiques, la fabrication et la distribution médicale et les produits biologiques.

1CM Inc. concentrates on non-psychoactive hemp derived products for the health and wellness market. The Company’s global capabilities position it to become a leading multi-jurisdictional cannabinoid producer – one that brings together the best cannabinoid products, brands and expertise from Canada and around the world. The 1CM portfolio currently comprises Jekyll+Hyde Brand Builders Inc., a marketing services agency specializing in the cannabis/hemp sector; Leviathan US Inc., which is manufacturing cannabinoid products from its facility in Smith County, Tennessee; LCG Holdings Inc., which intends to build a facility and cultivate hemp and manufacture cannabidiol extracted products in Carmen de Viboral, Colombia; and Woodstock Biomed Inc., which owns a 30-acre property with greenhouse infrastructure in Pelham, Ontario. The Woodstock property operates under a lease agreement with Medical Saints Ltd., a Health Canada regulated licensed producer of industrial hemp. 

4Front Ventures Corp. is a vertically-integrated cannabis company with cultivation, production and retail facilities spread across several states in the US.

Share Classes

4Front has two classes of shares: subordinate voting shares (“SVS”) and multiple voting shares (“MVS”). SVS are publicly traded on the CSE and are entitled to one vote.  MVS are not publicly traded, can convert to SVS at a ratio of 1 MVS to 1 SVS, and are entitled to 800 votes per MVS.

There are 640,386,686 SVS outstanding and 1,276,208 MVS convertible to 1,276,208 outstanding for a total outstanding SVS of 641,662,894 on an as-converted basis.

Please see Section 10 - Description of Securities of 4Front's Form 2A Listing Statement for a further description of the SVS and MVS.

Headquartered in New York City, Acreage is a vertically integrated, multi-state operator of cannabis ‎licenses and assets in the U.S. Acreage is dedicated to building and scaling operations to create a ‎seamless, consumer-focused branded cannabis experience. Acreage debuted its national retail store ‎brand, The Botanist in 2018 and its award-winning consumer brands, The Botanist and Live Resin Project ‎in 2019.‎

Class E subordinate voting share (each, a “Fixed Share”) of the Company was created pursuant to the Amended Plan of Arrangement.  Each Fixed Share entitles the holder to one vote per share at shareholder meetings of the Company. Each Fixed Share is subject to an option (the “Canopy Option”) in favour of Canopy Growth Corporation (“Canopy Growth”) pursuant to which Canopy Growth may, upon satisfaction or waiver of the conditions set out in the Amended Arrangement Agreement, acquire the Fixed Shares (the “Acquisition”).  The  Canopy Option is required to be exercised upon the occurrence of changes in U.S. federal law to permit the general cultivation, distribution, and possession of marijuana and subject to the satisfaction or waiver of certain conditions to closing as set out in the Amended Arrangement Agreement, the Acquisition will be completed.

Investor Note: In addition to the 71,343,094 Fixed Shares and 30,626,805 Floating Shares that are listed and trading, there are 17,017,664 Fixed Shares and 7,242,885 Floating Shares, respectively, reserved for issuance pursuant to redemption and conversion rights attached to other share classes of Acreage Holdings, Inc., as well as certain outstanding securities of Acreage Holdings WC, Inc. and High Street Capital Partners, LLC, which are subsidiaries of Acreage Holdings, Inc. The total number of Fixed Shares and Floating Shares, as converted, is 88,360,758 and 37,869,690, respectively, excluding options, warrants, RSUs and convertible debt.

Headquartered in New York City, Acreage is a vertically integrated, multi-state operator of cannabis ‎licenses and assets in the U.S. Acreage is dedicated to building and scaling operations to create a ‎seamless, consumer-focused branded cannabis experience.

A Class D subordinate voting share (each, a “Floating Share”) of the Company was created pursuant to the Amended Plan of Arrangement.  Each Floating Share entitles the holder thereof to one vote per share at shareholder meetings of the Company. Each Fixed Share is subject to an option in favor of Canopy Growth (the “Floating Call Option”) to acquire all of the issued and outstanding Floating Shares.  If exercised in accordance with the terms of the Amended Plan of Arrangement, Canopy Growth’s acquisition of the Floating Shares will take place concurrently with, and subject to satisfaction or waiver of the same conditions as, the Acquisition.

Investor Note: In addition to the 71,182,977 Fixed Shares and 30,558,196 Floating Shares that are listed and trading, there are 17,017,664 Fixed Shares and 7,242,885 Floating Shares, respectively, reserved for issuance pursuant to redemption and conversion rights attached to other share classes of Acreage Holdings, Inc., as well as certain outstanding securities of Acreage Holdings WC, Inc. and High Street Capital Partners, LLC, which are subsidiaries of Acreage Holdings, Inc. The total number of Fixed Shares and Floating Shares, as converted, is 88,200,641 and 37,801,081, respectively, excluding options, warrants, RSUs and convertible debt.

 

Adastra Holdings Ltd. is a Health Canada licensed high-quality agricultural scale cannabis extraction, distillation, and concentrate B2B producer in addition to white-label product extraction, formulation, manufacturing, sales (edibles, extracts, and topicals), and R&D (human testing for taste of various cannabis products for assessment of taste, sights, smell, or touch) with its recent license addendum.

The Company's 13,000 sq ft facility, built and operated under GMP standards, is located in Langley, British Columbia with operations through its wholly-owned subsidiaries Adastra Labs Inc. for Standard Processing (no growing), sales, and R&D along with Chemia Analytics Inc. as its in-house Analytical Testing Laboratory.

Affinor is focused on the design, development and commercialization of vertical farming technology for both indoor and outdoor (greenhouse) applications. The team is currently working on demand crops such as romaine lettuce and strawberries by developing processes, methods and models to cultivate true perpetual crops at competitive pricing. It is the mission of Affinor to be the world-wide technology and market leader in creating and commercializing the most economical vertical farming technologies that use the least possible resources (eg. land, water, and energy resources) to produce the highest quality pesticide-free produce year-round, regardless of environmental conditions. Affinor’s patent technology and licensed patent pending technology positions the Company well in the vertical farming industry. It is the only vertically integrated technology that can offer patented inline automated pollination for fruiting crops. Affinor can offer software driven growing solutions automating high quality, scientifically engineered products and process.

AgraFlora Organics International Inc. has an experienced management team with a growth strategy to develop a diversified portfolio of projects that can be taken into production. The Company’s main objective is to add shareholder value through cost efficient acquisitions, joint ventures, and effective marketing while maintaining a lower risk profile through project diversification and sound financial management.

L'émetteur est un fournisseur de solutions de santé numériques utilisant une combinaison exclusive de dispositifs de surveillance numérique de la santé, de logiciels basés sur l'IA et d'une plate-forme de cloud computing qui se combinent pour aider les soignants, les patients et les professionnels de la santé à accéder et à utiliser les données de santé pertinentes.

Aion Therapeutic Inc. est une société d’extraction de cannabinoïdes en phase initiale basée à Oliver, en Colombie-Britannique. Aion a demandé une licence de traitement standard en vertu de la loi sur le cannabis pour son installation de 10 410 pi2 et cette demande en est actuellement au stade de la révision. La société proposera l’extraction à forfait, la vente d’huile en vrac et le développement de produits de marque exclusive Aion et de produits marqués en blanc une fois autorisés à le faire.

Albert Labs International Corp. est une entreprise de recherche clinique et de développement de médicaments en laboratoire qui répond aux besoins en matière de soins de santé mentale. Grâce à un parcours clinique succinct, axé sur les preuves du monde réel (RWE), Albert Labs cherche à commercialiser ses traitements à base de psychédéliques et, ce faisant, à proposer plus tôt une psychothérapie assistée par psychédélique aux patients. Axé sur l'accélération de l'accès et des approbations plus rapides, Albert Labs donne la priorité aux patients ayant des besoins urgents et non satisfaits en développant des médicaments sous licence pour traiter une variété de problèmes de santé mentale. La détresse liée au cancer, un objectif initial du programme de développement d'Albert Labs, toucherait plus de 16 millions de patients dans le monde.

Advertisement

Publicité

Dernières nouvelles CSE

Évènements à venir

2022-11-28-Saskatchewan-Geological-Open-House_Website.jpg

Saskatchewan Geological Open House

Lundi, novembre 28, 2022 - 13:00 - Mercredi, novembre 30, 2022 - 17:00
2022-12-01-Toronto-Investor-Series-at-The-Albany-Club_Website.jpg

Toronto Investor Series at The Albany Club

Jeudi, décembre 1, 2022 -
13:00 - 17:30

Advertisement

Publicité